Health Reviews Labs covers osteoarthritis and joint mobility formulas — hyaluronic acid and anti-inflammatory approaches, assessed against published clinical research.
Joint supplementation has long centered on glucosamine, despite genuinely mixed clinical results across large trials. Our coverage focuses on formulas taking a different, multi-mechanism approach — directly supporting joint fluid lubrication and reducing inflammation simultaneously, rather than relying solely on cartilage building blocks.
Osteoarthritis, the gradual breakdown of cartilage and reduced synovial fluid lubrication, affects a substantial share of adults over 50, particularly in weight-bearing joints like knees and hips. The formula we cover addresses both the lubrication and inflammatory components directly.
Hyaluronic acid is a primary component of synovial fluid, the substance lubricating joints and absorbing mechanical shock. In osteoarthritis, both the concentration and quality of joint fluid hyaluronic acid tend to decrease. Specific patented forms engineered for oral bioavailability address the absorption challenge that limits many generic hyaluronic acid supplements.
Boswellia Serrata has substantial research examining its effect on inflammatory cytokines relevant to joint tissue, with multiple controlled trials showing reduced pain and stiffness scores in osteoarthritis patients independent of the lubrication mechanism.
Glucosamine targets cartilage building blocks specifically, but doesn't address joint fluid lubrication or inflammation directly. Several large trials, including NIH-funded research, found effects similar to placebo for many users — which is part of why multi-mechanism formulas have gained traction as alternatives.
Editorial Disclosure: Health Reviews Labs analyzes supplement formulas editorially. Some links on this page are affiliate links — we may earn a commission at no additional cost to you. This does not influence our analysis. See our Affiliate Disclosure. Not medical advice. Always consult your healthcare provider.